Colipano, Justine .

HRN: 15-13-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2024
CEFUROXIME 750MG (VIAL)
03/24/2024
03/30/2024
IVT
650mg
Q8
T/C UTI; WBC At 39.3
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: